0 CAD 0.00
items in your cartto quote Checkout
Ooops no items were found.
Try something else.
Ok
Loading…
<p>The Health Canada Approved COVID-19 Antibody Rapid Test is a lateral flow in-vitro immunoassay intended to detect the presence of SARS-CoV-2 IgM and IgG antibodies instantly from a whole blood sample collected from a minimally invasive fingerstick blood collection process.</p>
<p>The test is intended for both laboratory and point-of-care settings (POC).</p>
<p><strong>Benefits</strong></p>
<ul>
<li>Easy to use</li>
<li>2-step procedure</li>
<li>FDA EUA-approved, CLIA - waived</li>
<li>Rapid results within 15 minutes</li>
</ul>
<p><strong>Contents</strong></p>
<ul>
<li>20x Test Devices</li>
<li>20x Disposable Pipettes</li>
<li>20x Alcohol Prep Pads</li>
<li>20x Sterile Safety Lancets</li>
<li>1x Sample Diluent</li>
<li>1x Instructions For Use (IFU)</li>
</ul>
<p><strong>Specification</strong></p>
<ul>
<li>IgG sensitivity: 90.0%, specificity: 100.0%. IgM sensitivity: 100.0%, specificity: 98.8%.</li>
<li>Overall positive agreement rate of 80.8%, negative agreement rate of 100.0%.</li>
<li>Sample Type: Fingertip blood, whole blood sample, serum and plasma</li>
<li>Detection Method: Colloidal Gold</li>
<li>Detection Time: 10 – 15 minutes</li>
<li>Suitable for Point of Care Testing, CLIA waived</li>
<li>FDA EUA approved; CE Certified, Health Canada approved</li>
</ul>

FaStep COVID-19 IgM/IgG Antibody Rapid Test

Item Code: 815-26800A
Manufacturer Ref 26800

Description

The Health Canada Approved COVID-19 Antibody Rapid Test is a lateral flow in-vitro immunoassay intended to detect the presence of SARS-CoV-2 IgM and IgG antibodies instantly from a whole blood sample collected from a minimally invasive fingerstick blood collection process.

The test is intended for both laboratory and point-of-care settings (POC).

Benefits

  • Easy to use
  • 2-step procedure
  • FDA EUA-approved, CLIA - waived
  • Rapid results within 15 minutes

Contents

  • 20x Test Devices
  • 20x Disposable Pipettes
  • 20x Alcohol Prep Pads
  • 20x Sterile Safety Lancets
  • 1x Sample Diluent
  • 1x Instructions For Use (IFU)

Specification

  • IgG sensitivity: 90.0%, specificity: 100.0%. IgM sensitivity: 100.0%, specificity: 98.8%.
  • Overall positive agreement rate of 80.8%, negative agreement rate of 100.0%.
  • Sample Type: Fingertip blood, whole blood sample, serum and plasma
  • Detection Method: Colloidal Gold
  • Detection Time: 10 – 15 minutes
  • Suitable for Point of Care Testing, CLIA waived
  • FDA EUA approved; CE Certified, Health Canada approved

Specifications

Made In

CA

Brand

Own Brand

Category

Point Of Care Antibody Testing

Cover Width

Rapid COVID-19 Testing

- +
Compare
<p>The Health Canada Approved COVID-19 Antibody Rapid Test is a lateral flow in-vitro immunoassay intended to detect the presence of SARS-CoV-2 IgM and IgG antibodies instantly from a whole blood sample collected from a minimally invasive fingerstick blood collection process.</p>
<p>The test is intended for both laboratory and point-of-care settings (POC).</p>
<p><strong>Benefits</strong></p>
<ul>
<li>Easy to use</li>
<li>2-step procedure</li>
<li>FDA EUA-approved, CLIA - waived</li>
<li>Rapid results within 15 minutes</li>
</ul>
<p><strong>Contents</strong></p>
<ul>
<li>20x Test Devices</li>
<li>20x Disposable Pipettes</li>
<li>20x Alcohol Prep Pads</li>
<li>20x Sterile Safety Lancets</li>
<li>1x Sample Diluent</li>
<li>1x Instructions For Use (IFU)</li>
</ul>
<p><strong>Specification</strong></p>
<ul>
<li>IgG sensitivity: 90.0%, specificity: 100.0%. IgM sensitivity: 100.0%, specificity: 98.8%.</li>
<li>Overall positive agreement rate of 80.8%, negative agreement rate of 100.0%.</li>
<li>Sample Type: Fingertip blood, whole blood sample, serum and plasma</li>
<li>Detection Method: Colloidal Gold</li>
<li>Detection Time: 10 – 15 minutes</li>
<li>Suitable for Point of Care Testing, CLIA waived</li>
<li>FDA EUA approved; CE Certified, Health Canada approved</li>
</ul>

FaStep COVID-19 IgM/IgG Antibody Rapid Test

Item Code: 815-26800A
Manufacturer Ref 26800

Description

The Health Canada Approved COVID-19 Antibody Rapid Test is a lateral flow in-vitro immunoassay intended to detect the presence of SARS-CoV-2 IgM and IgG antibodies instantly from a whole blood sample collected from a minimally invasive fingerstick blood collection process.

The test is intended for both laboratory and point-of-care settings (POC).

Benefits

  • Easy to use
  • 2-step procedure
  • FDA EUA-approved, CLIA - waived
  • Rapid results within 15 minutes

Contents

  • 20x Test Devices
  • 20x Disposable Pipettes
  • 20x Alcohol Prep Pads
  • 20x Sterile Safety Lancets
  • 1x Sample Diluent
  • 1x Instructions For Use (IFU)

Specification

  • IgG sensitivity: 90.0%, specificity: 100.0%. IgM sensitivity: 100.0%, specificity: 98.8%.
  • Overall positive agreement rate of 80.8%, negative agreement rate of 100.0%.
  • Sample Type: Fingertip blood, whole blood sample, serum and plasma
  • Detection Method: Colloidal Gold
  • Detection Time: 10 – 15 minutes
  • Suitable for Point of Care Testing, CLIA waived
  • FDA EUA approved; CE Certified, Health Canada approved

Specifications

Made In

CA

Brand

Own Brand

Category

Point Of Care Antibody Testing

Cover Width

Rapid COVID-19 Testing

- +
Compare
SEARCH ×